
Bake Sale Raises Funds for ACGT
In a recent article in the New York Times, Arthur Brooks discusses why giving back can lead to happiness and the power that comes from “investing one’s own time, talent … Read More

“My research group is working to uncover the secrets of cancer and, more importantly, how to stop it,” said Stegh, a senior co-author of the study. “Glioblastoma is a very challenging cancer, and most chemo-therapeutic drugs fail in the clinic. The beauty of the gene we silenced in this study is that it plays many different roles in therapy resistance. Taking the gene out of the picture should allow conventional therapies to be more effective.” Read More…
“Our donors have allowed top scientific minds to explore this new and promising avenue of cancer treatment, and their philanthropy is directly linked to the … Read More…
2012 Young Investigator Grant Recipients Announced Dr. Alexander Stegh, Northwestern University and Dr. Douglas Mahoney, University of Calgary, Canada. Stegh’s research is focused on Glioblastoma. … Read More…
“Unfortunately, everybody is touched by cancer. So when you get this passionate group that’s trying to make a difference… it’s really an impact.” Janel Jorgensen … Read More…
A Celebration of Innovation & Dedication: ACGT’s 10th Anniversary honoring Edward Netter April 19, 2012 at 6:30 PM Hyatt Regency in Greenwich, Connecticut More than … Read More…
Learn more about exciting progress in targeted cancer therapies